Dergiler / Erciyes Medical Journal / 2020 / Cilt: 42 - Sayı: 3

Evaluation of Vitamin D Levels in the Course of Acute Rheumatic Fever with Active Carditis

Sayfa
312–316
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

These findings suggest that antiinflammatory and immunomodulatory effects of vitamin D.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Vitamin D is a hormone with immunomodulatory and anti-inflammatory effects besides calcium hemostasis.
📊
Temel Bulgular & Veri:Materials and Methods: Acute phase reactants, vitamin D levels and echocardiographic parameters of 25 patients with active carditis were evaluated at the time of the acute attack and in 1, 2 and 6 months of follow-up and compared to a control group of 25 age-and sex-matched healthy children.
💡
Sonuç & Katkı:These findings suggest that antiinflammatory and immunomodulatory effects of vitamin D.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Vitamin D is a hormone with immunomodulatory and anti-inflammatory effects besides calcium hemostasis. The present study aims to evaluate the relationship between acute rheumatic fever (ARF) attacks and vitamin D levels. Materials and Methods: Acute phase reactants, vitamin D levels and echocardiographic parameters of 25 patients with active carditis were evaluated at the time of the acute attack and in 1, 2 and 6 months of follow-up and compared to a control group of 25 age-and sex-matched healthy children. Results: At the time of diagnosis, WBC, ESR and CRP levels were significantly higher (p<0.05), and vitamin D levels were lower than the control group, not statistically significant (p=0.07). The mean vitamin D levels of the patients diagnosed in winter and spring-autumn seasons were 17.54±9.89 μg/L, and the rate of vitamin D deficiency was 47.3%. The mean vitamin D levels of the control group, in the same seasons, were 23.97±9.48 μg/L and the vitamin D deficiency rate was 19.1%. The vitamin D levels at the time of diagnosis of the ARF group were lower than the control group (p=0.038) and the attributed risk for vitamin D deficiency in ARF carditis in winter and spring seasons was found 3.46 (95% CI 1.1–5.14). Furthermore, cardiac parameters were significantly getting better, while vitamin D deficiency rates decreasing during the follow-up period. Conclusion: ARF attacks were found to be more frequent in non-summer seasons when vitamin D levels were lower. Echocardiographic and laboratory parameters improved with increasing vitamin D levels. These findings suggest that antiinflammatory and immunomodulatory effects of vitamin D.

🔖

Bu Makaleye Atıf Yap

TÜRKUÇAR, S., PAMUKÇU, Ö., ARGUN, M., ÖZYURT, A., NARİN, N. (2020). Evaluation of Vitamin D Levels in the Course of Acute Rheumatic Fever with Active Carditis. Erciyes Medical Journal, Cilt: 42 - Sayı: 3, 312–316. https://ajindex.com/articles/210813

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Narin N, Mutlu F, Argun M, Ozyurt A, Pamukcu O, Baykan A, et al. Incidence and clinical features of acute rheumatic fever in Kayseri, Central Anatolia, 1998-2011. Cardiol Young 2015; 25(4): 745–51
  2. Konig MF. The microbiome in autoimmune rheumatic disease. Best Pract Res Clin Rheumatol. 2020 Feb 7:101473. doi: 10.1016/j. berh.2019.101473. [Epub ahead of print]
  3. Sikder S, Rush CM, Govan BL, Alim MA, Ketheesan N. Anti-streptococcal antibody and T-cell interactions with vascular endothelial cells initiate the development of rheumatic carditis. J Leukoc Biol 2020; 107(2): 263–71
  4. Moretti R, Morelli ME, Caruso P. Vitamin D in Neurological Diseases: A Rationale for a Pathogenic Impact. Int J Mol Sci 2018; 19(8): 2245
  5. Marino R, Misra M. Extra-Skeletal Effects of Vitamin D. Nutrients 2019; 11(7): 1460
  6. Vanherwegen AS, Gysemans C, Mathieu C. Regulation of Immune Function by Vitamin D and Its Use in Diseases of Immunity. Endocrinol Metab Clin North Am 2017; 46(4): 1061–94
  7. Li S, Petraskova T, Stys N, Blue M, Stys T, Stys A. Dietary Supplement Use in Patients with Cardiovascular Disease. S D Med 2020; 73(2): 72–6
  8. Kanellopoulou A, Riza E, Samoli E, Benetou V. Dietary Supplement Use after Cancer Diagnosis in Relation to Total Mortality, Cancer Mortality and Recurrence: A Systematic Review and Meta-Analysis. Nutr Cancer 2020;1–15
  9. Dall’Ara F, Cutolo M, Andreoli L, Tincani A, Paolino S. Vitamin D and systemic lupus erythematous: a review of immunological and clinical aspects. Clin Exp Rheumatol 2018; 36(1): 153–62
  10. Aksan A, Tugal D, Hein N, Boettger K, Caicedo-Zea Y, Diehl I, et al. Measuring Vitamin D Status in Chronic Inflammatory Disorders: How does Chronic Inflammation Affect the Reliability of Vitamin D Metabolites in Patients with IBD? J Clin Med 2020; 9(2): 547
  11. Kim H, Baek S, Hong SM, Lee J, Jung SM, Lee J, et al. 1,25-dihydroxy Vitamin D3 and Interleukin-6 Blockade Synergistically Regulate Rheumatoid Arthritis by Suppressing Interleukin-17 Production and Osteoclastogenesis. J Korean Med Sci 2020; 35(6): e40
  12. Rhodes KL, Rasa MM, Yamamoto LG. Acute Rheumatic Fever: Revised Diagnostic Criteria. Pediatr Emerg Care 2018; 34(6): 436–40
  13. Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD, Ozono K, et al. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. J Clin Endocrinol Metab 2016; 101(2): 394–415
  14. Yamamoto EA, Jørgensen TN. Relationships Between Vitamin D, Gut Microbiome, and Systemic